Joint open Letter to the members of the JURI Committee from the Corporate Europe Observatory (CEO), The Medicines in Europe Forum (MiEF) and The International Society of Drug Bulletins (ISDB) calling on the members of the JURI Committee to ensure, through additional and more ambitious amendments, that both freedom of speech for journalists and their sources, including whistle-blowers, and access to regulatory and scientific data of public interest, are preserved.
Link to the PDF of the joint open letter below:
Attachment: jointopenletterjuri_meps.pdf